Peptide gel, CK2-085, maintains operative field visibility during surgery.
Peptide gel CK2-085 just put another win on the board for peptide research. This new gel shows it can keep the surgical field clear, giving surgeons exactly what they want: better visibility, less hassle. Forget the old methods—CK2-085 is a peptide-based hydrogel designed to stay put during procedures and not cloud up the view.
Sci Rep
by Matsushita K, Kawashima R, Uesugi K et al.
“Peptide gel, CK2-085, maintains operative field visibility during surgery. Matsushita K(1), Kawashima R(2), Uesugi K(2)(3), Usui S(2), Sakaguchi H(4)(5), Ueki M(6), Mori K(7), Otori Y(8), Okumichi H(5), Kiuchi Y(5), Sotozono C(7), Ikeda T(6), Inatani M(9), Quantock AJ(10), Nishida K(11)(12); SPG-178 Study Group. Collaborators: Kojima S, Kohmoto R, Ikeda Y, Jian K, Yuasa Y, Komatsu K. Author information: (1)Department of Ophthalmology, University of Osaka Graduate School of Medicine, Suita, 565-0871, Japan. kenmatsu@ophthal.med.osaka-u.ac.jp. (2)Department of Ophthalmology, University of Osaka Graduate School of Medicine, Suita, 565-0871, Japan. (3)Menicon Co., Ltd., Nagoya, Japan. (4)Department of Advanced Device Medicine, The University of Osaka Graduate School of Medicine, Suita, Japan. (5)Department of Ophthalmology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. (6)Department of Ophthalmology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. (7)Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. (8)Department of Ophthalmology, National Hospital Organization, Osaka National Hospital, Osaka, Japan. (9)Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Yoshida-gun, Japan. (10)School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK. (11)Department of Ophthalmology, University of Osaka Graduate School of Medicine, Suita, 565-0871, Japan. knishida@ophthal.med.osaka-u.ac.jp. (12)Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, Suita, Japan. knishida@ophthal.med.osaka-u.ac.jp. Conflict of interest statement: Declarations. Competing interests: Menicon (KN, HS), Employment: Menicon (KU), and Patent: Menicon (KN, KM, HS, and KU). The other authors declare that they have no conflicts of interest.”
Researchers in Japan put CK2-085 to the test during eye surgeries. The results? The gel maintained a stable, transparent layer. Blood and fluids didn’t mix and obscure the area, so surgeons could see what they were doing. That’s a big deal for precision work, especially in ophthalmology.
Why does this matter for the peptide community?
CK2-085 is a clean example of how peptides can be engineered into functional biomaterials.
The gel’s transparency and stability solve a real problem—operative field management during delicate procedures.
Using a peptide backbone allows for tunable properties, opening the door for similar gels in other surgical fields.
Peptide gels aren’t new. But CK2-085 pushes the category forward. It’s stable, it’s predictable, and it works under the stress of actual surgery. The research group, including industry partner Menicon, is betting hard on this as a platform for future surgical tools.
Key takeaway: This is more than a technical win. It’s proof that peptide-based biomaterials can deliver real-world improvements in surgical practice. If you’re researching peptide applications, keep an eye on CK2-085 and similar developments. Peptides just got a little more practical in the OR.
Related Reading
Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment.
News · JACC Heart FailSemaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment.
News · NeuropsychopharmacologyIdentification of an intrusive-hypervigilant phenotype of posttraumatic stress symptoms with unique stress peptide and amygdala functional connectivity profiles.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.